Alphabet: Consensus Earnings Estimates For Q1 2021

Alphabet (NASDAQ: GOOG) will be reporting their first quarter financial results on April 27th after market close. Analysts have a consensus $2,415 12-month price target on the company, via a total of 44 analysts, with 16 analysts having strong buy ratings. 26 analysts meanwhile have buy ratings and two analysts have hold ratings. The street high comes from Susquehanna Financial with a $3,000 price target, and the lowest target sits at $1,420.

29 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 29 analysts is $51.55 billion; this number has been revised upwards from $48.7 billion at the start of the year. The highest revenue estimate is $55.45 billion, while the lowest is $48.5 billion.

Onto EBITDA estimates, there are currently 24 analysts who have first-quarter EBITDA estimates. The mean is currently $19.1 billion, with this number having been revised upwards from $17.35 billion at the start of the year. Street high is a $22.3 billion EBITDA estimate and the lowest is $16.56 billion.

Analysts estimate that quarterly earnings per share will come in at $15.80, with this number being slightly revised up from $13.79 at the start of the year. The street high estimate is $19.44 and the lowest estimate is $11.47 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Drills 17.95 g/t Gold Over 22 Metres At Premier Mine

Denarius Metals Increases Bid For Emerita Resources To $0.45 Per Share

Related News

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM

Aritzia Sees Consensus Price Target Rise After Q2 Results

Aritzia (TSX: ATZ) last week reported its second quarter results for fiscal 2023, for the...

Wednesday, October 19, 2022, 12:44:00 PM

Kinross: BMO Lifts Target To $7.50 After Project Updates

On June 28, Kinross Gold Corporation’s (TSX: K) management provided an updated presentation on their...

Sunday, July 3, 2022, 05:11:00 PM

Lundin Gold Sees BMO Capital Markets Raise 2022 Production Estimates

Last week, Lundin Gold Inc. (TSX: LUG) announced its second-quarter production results. The company said...

Monday, July 11, 2022, 02:18:00 PM

Google Shuts Down Google Translate In Mainland China

Alphabet Inc (NASDAQ: GOOGL) continues its retreat from China. On Monday, the company pulled its...

Tuesday, October 4, 2022, 04:43:00 PM